Feb 19, 2019
Intec Pharma Reports Positive Results from Pharmacokinetic Study of Accordion Pill(TM) Carbidopa/Levodopa 50/500 mg Dosed Three Times Daily
Jan 15, 2019
Valeo Pharma and Zambon announce the approval of Onstryv® (safinamide) for Canada
Dec 26, 2018
Early Investment from Michael J. Fox Foundation Pushes New Parkinson's Treatment to Market
Oct 22, 2018
Intec Pharma Completes Enrollment of Pivotal Phase 3 Clinical Trial of Accordion Pill(TM) Carbidopa/Levodopa for the Treatment of Advanced Parkinson's Disease Patients
Sep 25, 2018
Intec Pharma to Present Multiple Posters at International Congress of Parkinson's and Movement Disorder Society
Jul 02, 2018
UCB Announces Approval of NEUPRO® in China to Treat Parkinson's Disease
May 31, 2018
Impel NeuroPharma Announces Initiation of Phase IIa Study of INP103 in Parkinson's Disease OFF Episodes
May 07, 2018
Amneal Initiates Phase 3 Study for IPX203, an Investigational Extended-Release Formulation of Carbidopa-Levodopa (CD-LD) in Advanced Parkinson's Disease Patients
Apr 24, 2018
Intec Pharma Presented Phase 1 PK and Safety Data From Accordion Pill Carbidopa/Levodopa at American Academy of Neurology Annual Meeting
Apr 04, 2018
Intec Pharma Announces Poster Presentation at American Academy of Neurology Annual Meeting
Apr 03, 2018
Intec Pharma Ltd. to Host Key Opinion Leader Luncheon on Novel Drug Delivery Solutions in the Treatment of Parkinson's Disease
Mar 12, 2018
Intec Pharma Partners with LTS for Manufacture of Accordion Pill Carbidopa/Levodopa for Treatment of Parkinson's Disease
Oct 27, 2017
Parkinson's Disease Treatment Market 6.1% CAGR to 2022 led by Carbidopa/Levodopa Segment
Oct 11, 2017
First Patient Treated With Titan Pharmaceuticals' Subdermal Implant For Parkinson's Disease
Aug 24, 2017
SynAgile Corporation Announces Closing of $10.4M Financing
Aug 15, 2017
Intec Pharma Announces Proposed Public Offering of Ordinary Shares